Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Privacy Bills Should Focus On Compliance Date, Preemption, Lobbyist Says

Executive Summary

Medical privacy legislation should focus on pushing back the compliance date of the HHS regulations and granting federal preemption of state privacy laws rather than addressing details of the regs, Healthcare Leadership Council Exec VP Alan Mertz said.

You may also be interested in...



HHS Privacy Regs Need FDA Clarification Guidance, Attorney Suggests

The application of HHS patient privacy regulations to ongoing clinical research overseen by FDA is one of five areas that need agency guidance and clarification, Hogan & Hartson attorney Robert Brady said at the Food & Drug Law Institute annual educational conference April 19.

HHS Privacy Reg Consent Process Will Be Clarified After Rules Take Effect

HHS plans to clarify prior consent requirements in the Health Insurance Portability and Accountability Act final privacy rule through future guidelines or modifications, the department said April 12.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037968

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel